首页> 外文OA文献 >109P: ALK activates ERK5, in both neuroblastoma and lung cancer – a putative therapeutic target in cancer treatment

【2h】

109P: ALK activates ERK5, in both neuroblastoma and lung cancer – a putative therapeutic target in cancer treatment

机译：109p：alk激活ERK5，在神经母细胞瘤和肺癌中 - 癌症治疗的推定治疗靶标

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
G. Umapathy;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Erratum: Targeting ALK: A promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma (Targeted Oncology (2012) 7 (199-210) DOI: 10.1007/s11523-012-0227-8) [J] . MoralesLaMadridA., CampbellN., SmithS., Targeted oncology . 2013,第4期

机译：勘误：靶向ALK：一种用于治疗非小细胞肺癌，非霍奇金淋巴瘤和神经母细胞瘤的有前途的策略（Targeted Oncology（2012）7（199-210）DOI：10.1007 / s11523-012-0227-8）
2. Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin’s lymphoma, and neuroblastoma [J] . Andres Morales La Madrid, Nicholas Campbell, Sonali Smith, Targeted Oncology . 2012,第3期

机译：针对ALK：治疗非小细胞肺癌，非霍奇金淋巴瘤和神经母细胞瘤的有前途的策略
3. Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma. [J] . Andres Morales La Madrid, Nicholas Campbell, Sonali Smith, Targeted oncology . 2012,第3期

机译：靶向ALK：治疗非小细胞肺癌，非霍奇金淋巴瘤和神经母细胞瘤的一种有前途的策略。
4. High throughput multiplexed phosphoproteomics identifies drivers of resistance to ALK inhibitor treatment in lung cancer [C] . Amanda L. Edwards, Luc Friboulet, Rosa Frias, ASMS Conference on Mass Spectrometry and Allied Topics . 2016

机译：高通量复用磷蛋白酶鉴定肺癌抗华抗抑制剂治疗的驱动因素
5. Pharmacology Profiles of ALK and FLT3 Kinase Inhibitors against Non-Small-Cell Lung Cancer Cells and Acute Myeloid Leukemia Cells with Cancer Driver Mutations [D] . 森政道 2019

机译：ALK和FLT3激酶抑制剂对非小细胞肺癌细胞和急性髓系白血病细胞的癌症驱动突变的药理作用
6. Transcriptomics-Guided Personalized Prescription of Targeted Therapeutics for Metastatic ALK-Positive Lung Cancer Case Following Recurrence on ALK Inhibitors [O] . Elena Poddubskaya, Alexey Bondarenko, Alexander Boroda, -1

机译：转录组学指导的针对ALK抑制剂复发后转移性ALK阳性肺癌病例的靶向治疗药物的个性化处方
7. Erratum to: Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin’s lymphoma, and neuroblastoma [O] . Andres Morales La Madrid, Nicholas Campbell, Sonali Smith, 2013

机译：错误：靶向ALK：一种治疗非小细胞肺癌，非霍奇金淋巴瘤和神经母细胞瘤的有希望的策略

109P: ALK activates ERK5, in both neuroblastoma and lung cancer – a putative therapeutic target in cancer treatment

著录项

引文网络

相似文献

相关主题

期刊订阅